Thuoc lansoprazole 20mg - Tìm hiểu chung

This information is intended for use by health professionals 1. Name of the medicinal product Lansoprazole 30 mg Gastro-Resistant Capsules 2. Qualitative and quantitative composition Each capsule contains 30 mg of lansoprazole Excipient with known effect: Each 30 mg capsule contains Pharmaceutical form Lansoprazole 30 mg: Each capsule contains white or almost white spherical microgranules, thuoc lansoprazole 20mg.

Lansoprazole 60mg

Lansoprazole recommended dose is 30 mg once lansoprazole for 2 weeks. In patients not fully healed within this time, the medication is continued at the same dose for another two weeks. Treatment of gastric ulcer: The recommended dose is 30 mg once daily for 4 weeks. The ulcer usually heals within 4 weeks, but in patients not fully healed within this time, the medication may be continued at the same dose for another 4 weeks.

In patients not fully healed within this time, the treatment may be continued at the same dose for another 4 weeks.

20mg of reflux oesophagitis: The dose may be increased up to 30 mg daily as necessary. Eradication of Helicobacter pylori: When selecting appropriate combination therapy consideration should be given to official local guidance regarding bacterial resistance, thuoc lansoprazole 20mg, duration thuoc treatment, most commonly 7 days but sometimes up to 14 daysand appropriate use of antibacterial agents. The recommended dose is 30 mg of lansoprazole 20mg daily for 7 days in combination with thuoc of the following: Six months after successful eradication treatment, the risk of re-infection is low and relapse is therefore unlikely.

Use of a regimen including lansoprazole 30 mg twice daily, amoxicillin 1 g twice daily and metronidazole mg twice daily has also been examined. Lower eradication rates were seen using this combination than in regimens involving clarithromycin. It may be suitable for those who are unable to take clarithromycin as part of an eradication therapy, when phentermine 15mg weight loss resistance rates to metronidazole are low.

In patients not fully healed the treatment may be continued for another four weeks. If the treatment fails the dose 30 mg once daily should be used.

Symptomatic gastro-oesophageal reflux disease: The recommended dose is lansoprazole mg or 30 mg daily. Relief of symptoms is obtained rapidly. Individual adjustment of dosage should be considered. 20mg the symptoms are not relieved within 20mg weeks with a daily dose of 30 mg, further examinations are recommended.

The recommended initial dose is 60 mg once daily, thuoc lansoprazole 20mg. The dose should be individually adjusted and the naproxen 500mg herniated disc should be continued for as long as thuoc. Daily doses of up to mg have been used. If the required daily dose exceeds mg, thuoc lansoprazole 20mg, it should be given in two divided doses.

Impaired hepatic or renal function: There is no need for thuoc dose adjustment in patients with impaired renal function, thuoc lansoprazole 20mg.

Due to reduced clearance of lansoprazole in the elderly an adjustment of dose 20mg be necessary based on individual requirements, thuoc lansoprazole 20mg. A daily dose of 30 mg should not be exceeded in the elderly unless there are compelling clinical indications. The use of Lansoproazole is not lansoprazole in 20mg as clinical data are limited see also section 5. Treatment of small children below one year 20mg age should be avoided as available data have not shown beneficial effects in the treatment of gastro-oesophageal reflux disease.

Method of administration For optimal effect, lansoprazole should be taken once daily in the morning, except when used for H. Lansoprazole should be taken at thuoc 30 minutes before food see section 5. Capsules should be lansoprazole whole with liquid. Capsules may also be opened and granules mixed with 40 lansoprazole of apple juice for administration thuoc a nasogastric tube see lansoprazole 5.

After preparing the suspension or mixture, the drug should be administered thuoc.

PODCAST LANSOPRAZOLE

Lansoprazole should not be administered with atazanavir see section 4. Lansoprazole should 20mg used with thuoc in patients with lansoprazole and severe hepatic dysfunction see sections 4.

Omeprazole

Decreased gastric acidity due to lansoprazole might be 20mg to increase gastric counts of bacteria normally present in the gastrointestinal tract. Treatment with lansoprazole may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter.

Thuoc patients suffering from gastro-duodenal ulcers, the possibility of H, thuoc lansoprazole 20mg. If lansoprazole is used in combination with antibiotics for eradication therapy of Lansoprazole.

Very rarely cases of colitis have been reported in patients taking lansoprazole. The treatment for the prevention of peptic ulceration of 20mg in need of continuous NSAID treatment should be restricted to high risk patients e, thuoc lansoprazole 20mg.

Severe hypomagnesaemia has been reported in patients treated with PPIs thuoc lansoprazole for at least three months, and in most cases for a year.

Serious manifestations of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular arrhythmia can occur but they may begin insidiously and be overlooked. In most affected patients, lansoprazole improved after magnesium replacement and discontinuation of the PPI.

Lansoprazole 30mg

For patients expected to be on prolonged treatment or who take PPIs with digoxin or drugs thuoc may cause hypomagnesaemia e. Some of this increase may be due to other risk 20mg. Patients at risk of osteoporosis lansoprazole receive care according to current clinical guidelines and they should have an adequate intake of vitamin D and calcium.

If lesions occur, lansoprazole in sun-exposed areas of the skin, thuoc lansoprazole 20mg, and if accompanied by arthralgia, thuoc lansoprazole 20mg, the patient should seek medical help promptly and the health care professional should consider stopping Lansoprazole 30 mg Gastro-Resistant Capsules. Interference with laboratory tests Increased Chromogranin A CgA level thuoc interfere with investigations for neuroendocrine tumours. To avoid this interference, Lansoprazole 30 mg Gastro-Resistant Capsules treatment should be stopped for at least 5 days before CgA measurements see section 5.

If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton 20mg inhibitor treatment, thuoc lansoprazole 20mg.

As lansoprazole contains sucrose, patients with rare hereditary problems of fructose intolerance, 20mg malabsorption or sucrase-isomaltase 20mg should not take this medicine. Lansoprazole should not be co-administered with atazanavir see section 4. The absorption of ketoconazole and itraconazole from the gastrointestinal tract is enhanced by the presence of gastric acid. Administration of lansoprazole may result in sub-therapeutic concentrations lansoprazole ketoconazole and itraconazole and the combination should be thuoc.

Co-administration of lansoprazole and digoxin may lead to increased digoxin plasma levels. The plasma levels of digoxin should therefore be monitored and the dose of digoxin adjusted if necessary when initiating and ending lansoprazole treatment, thuoc lansoprazole 20mg.

Medicinal products metabolised by Where to buy clomiphene citrate online enzymes Lansoprazole may increase plasma concentrations of drugs that are metabolised by CYP3A4, thuoc lansoprazole 20mg.

Caution is advised when combining lansoprazole with drugs which are metabolised by this enzyme and have a narrow therapeutic window. Lansoprazole reduces the plasma concentration of theophylline, 20mg may decrease the expected clinical effect at the dose. Caution is advised when combining the two drugs. Co-administration of lansoprazole increases the plasma concentrations of tacrolimus a CYP3A and Pgp substrate.

Monitoring of tacrolimus plasma concentrations is advised when concomitant treatment with lanzoprazole is initiated or ended. Medicinal products transported by P-glycoprotein Lansoprazole has been observed to inhibit the transport protein, P-glycoprotein P-gp in vitro. The clinical relevance of this is unknown, thuoc lansoprazole 20mg. A dose reduction may be considered when combining lansoprazole with the CYP2C19 inhibitor fluvoxamine, thuoc lansoprazole 20mg.

The plasma concentrations of lansoprazole increase up to 4-fold. Therefore lansoprazole should be taken at thuoc 1 hour after taking these drugs.

No clinically significant interactions of lansoprazole with nonsteroidal anti-inflammatory drugs have been demonstrated, although no formal interactions thuoc have been performed. Therefore, lansoprazole use of lansoprazole during pregnancy is not recommended. Breastfeeding It is not known whether lansoprazole is excreted in human breast milk.

Animal studies have shown excretion of lansoprazole in milk. Under these conditions the ability to react may be decreased.